Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2191]
News [5868]
Articles [116]
Editorials [31]
Conferences [186]
elearning [22]
Cost-effectiveness of metronomic approach to neuroblastoma and its use in...
Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic
Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies ( Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic )
10 Jul 2014
Quality of life and cost advantages of metronomics and drug repurposing
Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK
Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )
10 Jul 2014
Betablockers repurposed to treat neuroblastoma
Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia
Betablockers repurposed to treat neuroblastoma ( Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia )
10 Jul 2014
WIN consortium as a basis for forming cross-border collaborations for improving...
Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA
WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )
26 Jun 2014
Work of the WIN consortium and challenges of personalised cancer therapy
Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston...
Work of the WIN consortium and challenges of personalised cancer therapy ( Prof John Mendelsohn - University of Texas MD Anderson Cancer Center, Houston, USA )
26 Jun 2014
ARC Foundation's work and aims
Dr Jacques Raynaud - Foundation ARC pour la Recherche Cancer, Villejuif, France
ARC Foundation's work and aims ( Dr Jacques Raynaud - Foundation ARC pour la Recherche Cancer, Villejuif, France )
26 Jun 2014
ecancermedicalscience editor's choice for June 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience editor's choice for June 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
24 Jun 2014
Personalised medicine in Europe needs to be accessible to all
Prof Mark Lawler - Queen's University Belfast, Belfast, UK
Personalised medicine in Europe needs to be accessible to all ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )
20 Jun 2014
Advances in diagnostic devices in melanoma screening
Dr Alessandro Testori - European Institute of Oncology, Milan, Italy
Advances in diagnostic devices in melanoma screening ( Dr Alessandro Testori - European Institute of Oncology, Milan, Italy )
6 Jun 2014
Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid...
Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France
Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )
2 Jun 2014
Emerging pathways in immunotherapy
Prof Christopher Höller - Medical University of Vienna, Vienna, Austria
Emerging pathways in immunotherapy ( Prof Christopher Höller - Medical University of Vienna, Vienna, Austria )
20 May 2014
Cancer evasion of the immune system: the fundamentals
Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland
Cancer evasion of the immune system: the fundamentals ( Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland )
20 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation